Clinical Trial Update: Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and tolerability of AIN457 in adults with moderate to severe ankylosing spondylitis has been completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• AIN457

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED | Results posted: 2021-06-24